IP Library Granted Patent US 9,522,161
Granted Patent B2
US 9,522,161 · App. 14/668,087 · Granted Dec 20, 2016

Performance enhancing composition and method of delivering nutrients

Inventors: Ralph Mario Ferrante (Upper Grandview, NY); Chad Kevin Cunningham (Tappan, NY)
Assignee: Advanced Bio Development, Inc.
A61K31/7076A23L2/02A23L2/39A23L2/395A23L2/44A23L2/52A23L2/56A23L2/58A23L2/66A23L2/68A23L5/40A23L5/51A23L27/00A23L29/00A23L29/30A23L33/10A23L33/15A23L33/16A23P10/10A23P10/20A61K31/047A61K31/122A61K31/522A61K31/7004A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,161
App. No.
14/668,087
Granted
Dec 20, 2016
Kind
B2
Abstract

An aqueous composition specifically adapted for supporting physical performance. The liquid composition comprises, consists of, or consists essentially of ribose, a saccharide such as glucose or dextrose, coenzyme Q10, ATP, caffeine, and D-pinitol in conjunction with minerals and electrolytes. The orally-consumed liquid composition may be sold as a shelf-stable ready-to-drink liquid, or as a liquid concentrate or in solid form, such as a powder, granulate, or tablet to be added to water or other fluid. The liquid composition physiologically enhances essential energy stores and provides a supply of ingredients which support physiological generation and regeneration of ATP.

Claims (77)

1. A nutraceutical liquid composition consisting of:

a saccharide which is glucose or dextrose in the range of from about 15 to about 340 grams per liter of the liquid;

ribose in the range of from about 25 to about 85 grams per liter of the liquid;

coenzyme Q10 in the range of from about 15 milligrams to about 5 grams per liter of the liquid;

ATP disodium in the range of from about 15 milligrams to about 17 grams per liter of the liquid;

caffeine in the range of from about 415 milligrams to about 17 grams per liter of the liquid;

D-pinitol in the range of from about 15 milligrams to about 17 grams per liter of the liquid;

sodium in the range of from about 15 milligrams to about 5 grams per liter of the liquid;

potassium in the range of from about 15 milligrams to about 3.5 grams per liter of the liquid;

calcium in the range of from about 15 milligrams to about 2 grams per liter of the liquid;

magnesium in the range of from about 15 milligrams to about 2 grams per liter of the liquid;

a preservative;

an acidulant;

a flavoring agent;

a colorant; and

a liquid.

2. An individual serving of a nutraceutical composition consisting of:

about 3 gm ribose;

about 100 mg coenzyme Q10;

about 250 mg adenosine triphosphate (ATP) disodium;

about 70 mg caffeine;

about 30 mg D-pinitol;

about 12.5 gm dextrose or glucose;

about 180 mg trisodium citrate;

about 24 mg sodium benzoate;

about 164 mg monopotassium phosphate;

about 24 mg potassium sorbate;

about 500 mg citric acid;

about 215 mg calcium lactate;

about 210 mg magnesium lactate;

a flavoring agent; and

a colorant,

and optionally a liquid, one or more excipients, or both.

3. The composition according to claim 2 , wherein the composition is formulated in a tablet, powder, granulate, stick-pack, ready-to-dissolve concentrate, liquid concentrate, or a liquid formulation.

4. An individual serving of a nutraceutical composition consisting of:

(a) about 3 gm ribose; about 100 mg coenzyme Q10; about 250 mg adenosine triphosphate (ATP) disodium; about 70 mg caffeine; about 30 mg D-pinitol; and about 12.5 gm dextrose or glucose; and

(b) one or more components selected from the group consisting of:

sodium in the range of from about 15 milligrams to about 5 grams per liter of a ready-to-drink aqueous formulation of the composition;

potassium in the range of from about 15 milligrams to about 3.5 grams per liter of the ready-to-drink formulation;

calcium in the range of from about 15 milligrams to about 2 grams per liter of the ready-to-drink formulation;

magnesium in the range of from about 15 milligrams to about 2 grams per liter of the ready-to-drink formulation;

a preservative, an acidulant, a flavoring agent, a colorant, and combinations thereof, and optionally a liquid, one or more excipients, or both.

5. The composition according to claim 4 , wherein the composition is formulated in an aqueous ready-to-drink liquid or a liquid concentrate for reconstitution with a liquid prior to consumption.

6. The composition according to claim 4 , wherein the composition is formulated in a solid formulation for reconstitution by a consumer with a liquid prior to consumption.

7. The composition according to claim 1 , wherein the liquid is water or juice.

8. A solid formulation comprising the composition according to claim 6 , wherein the solid formulation is formulated in a tablet, powder, granulate, stick-pack, or ready-to-dissolve solid.

9. A solid formulation comprising the composition according to claim 4 , wherein the solid formulation comprises one or more excipients.

10. An individual serving of a nutraceutical composition consisting of:

3 gm ribose;

100 mg coenzyme Q10;

250 mg adenosine triphosphate (ATP) disodium;

70 mg caffeine;

30 mg D-pinitol;

12.5 gm dextrose or glucose;

180 mg trisodium citrate;

24 mg sodium benzoate;

164 mg monopotassium phosphate;

24 mg potassium sorbate;

500 mg citric acid;

215 mg calcium lactate;

210 mg magnesium lactate;

a flavoring agent;

a colorant, and optionally:

water, juice, or both; and/or

one or more excipients.

11. The composition according to claim 10 , wherein the composition is formulated in a tablet, powder, granulate, stick-pack, ready-to-dissolve concentrate, or a liquid formulation.

12. An individual serving of a nutraceutical composition consisting of:

(a) 3 gm ribose; 100 mg coenzyme Q10; 250 mg adenosine triphosphate (ATP) disodium; 70 mg caffeine; 30 mg D-pinitol; and 12.5 gm dextrose or glucose; and

(b) one or more components selected from the group consisting of:

sodium in the range of from 15 milligrams to 5 grams per liter of a ready-to-drink aqueous formulation of the composition;

potassium in the range of from 15 milligrams to 3.5 grams per liter of the ready-to-drink formulation;

calcium in the range of from 15 milligrams to 2 grams per liter of the ready-to-drink formulation;

magnesium in the range of from 15 milligrams to 2 grams per liter of the ready-to-drink formulation;

a preservative, an acidulant, a flavoring agent, a colorant, and combinations thereof; and

optionally a liquid, one or more excipients, or both.

13. The composition according to claim 12 , wherein the composition is formulated in an aqueous liquid or a liquid concentrate.

14. The composition according to claim 12 , wherein the composition is formulated in a tablet, powder, granulate, stick-pack, or ready-to-dissolve concentrate.

Assignments (2)
SECURITY INTEREST Recorded Aug 25, 2022
From: ADVANCED BIO DEVELOPMENT, INC.
To: SILICON VALLEY BANK
Reel/Frame 060900/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2016
From: FERRANTE, RALPH MARIO; CUNNINGHAM, CHAD KEVIN
To: ADVANCED BIO DEVELOPMENT, INC.
Reel/Frame 039202/0896 →
Continuity (3)
Continuation In Part 13238483 · Sep 21, 2011
Continuation In Part 12911925 · Oct 26, 2010
Related Publication 20150196579A1 · Jul 16, 2015